Clinical Scorecard: Obturator Nerve Dysfunction Associated with Lymphadenopathy in Systemic Lupus Erythematosus: A Diagnostic Challenge Across Disciplines

At a Glance

Key Highlights

• Obturator neuropathy caused by lymphadenopathy is a rare manifestation of SLE and can mimic primary myositis.
• MRI including pelvic imaging is critical to identify lymph node enlargement compressing the obturator nerve.
• High-dose oral prednisolone leads to rapid clinical and radiological improvement, confirming SLE-related lymphadenopathy as the cause.

Guideline-Based Recommendations

Diagnosis

• Consider obturator nerve compression in SLE patients with thigh pain and hip movement restriction.
• Use MRI including pelvic region to assess lymphadenopathy and nerve involvement.
• Perform lymph node biopsy to exclude lymphoma and confirm reactive changes related to SLE.

Management

• Initiate high-dose oral corticosteroids (e.g., prednisolone) with rapid tapering in stable patients without life-threatening organ involvement.
• Avoid misdiagnosis as primary myositis to prevent inappropriate treatment.
• Employ interdisciplinary evaluation involving rheumatology, neurology, radiology, and pathology.

Monitoring & Follow-up

• Monitor clinical symptoms and repeat imaging to assess lymph node size and nerve compression.
• Evaluate for treatment response through symptom improvement and radiological regression of lymphadenopathy.

Risks

• Potential misinterpretation as hydroxychloroquine-induced myopathy or primary myositis.
• Risk of overlooking lymphoma necessitates thorough biopsy and serological screening.
• Side effects related to high-dose corticosteroid therapy.

Patient & Prescribing Data

Young adult female with longstanding SLE and intermittent cutaneous and arthritic manifestations

Hydroxychloroquine intolerance and reduced efficacy led to methotrexate use; high-dose prednisolone effectively treated lymphadenopathy-associated obturator neuropathy.

Clinical Best Practices

• Maintain high suspicion for nerve compression by lymphadenopathy in SLE patients with atypical musculoskeletal symptoms.
• Incorporate pelvic MRI in imaging protocols when initial limb imaging is inconclusive.
• Use biopsy and serological testing to exclude malignancy and infections before attributing lymphadenopathy to SLE.
• Apply interdisciplinary diagnostic and therapeutic approaches to optimize patient outcomes.

References

• Hydroxychloroquine-induced myopathy in SLE